Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 10, 2014, Pages 1137-1143

  Spoto, B ^a   Di Betta, E ^b   Mattace Raso, F ^c   Sijbrands, E ^c   Vilardi, A ^b   Parlongo, R M ^a   Pizzini, P ^a   Pisano, A ^a   Vermi, W ^d   Testa, A ^a   Cutrupi, S ^a   D'Arrigo, G ^a   Lonardi, S ^d   Tripepi, G ^a   Cancarini, G ^d   Zoccali, C ^a  

^a CNR   (Italy)

^b SPEDALI CIVILI   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Adipose tissue; Gene expression; Inflammation; Obesity

Indexed keywords

ADIPONECTIN; CD163 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; LEPTIN; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; INTERLEUKIN 16; SAA1 PROTEIN, HUMAN; SERUM AMYLOID A;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CELL COUNT; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; INTRAABDOMINAL FAT; MALE; OBESITY; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; UPREGULATION; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED; OBESITY, MORBID;

ADULT; BARIATRIC SURGERY; BODY MASS INDEX; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; INTERLEUKIN-16; INTERLEUKIN-18; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY, MORBID; SERUM AMYLOID A PROTEIN; SUBCUTANEOUS FAT;

EID: 84908542420     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.04.017     Document Type: Article

References (30)

1. Frühbeck G. Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol Biol 2008, 456:1-22.
2. Evans D.J., Hoffman R.G., Kalkhoff R.K., Kissebah A.H. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 1984, 33:68-75.
3. Garg A. Regional adiposity and insulin resistance. J Clin Endocrinol Metab 2004, 89:4206-4210.
4. Matsuzawa Y., Shimomura I., Nakamura T., Keno Y., Kotani K., Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obes Res 1995, 3(Suppl. 2):187S-194S.
5. McLaughlin T., Lamendola C., Liu A., Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab 2011, 96:E1756-E1760.
6. Jensen M.D., Johnson C.M. Contribution of leg and splanchnic free fatty acid (FFA) kinetics to postabsorptive flux in men and women. Metabolism 1996, 45:662-666.
7. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355.
8. Vohl M.C., Sladek R., Robitaille J., Gurd S., Marceau P., Richard D., et al. A survey of genes differentially expressed in subcutaneous and visceral adipose tissue in men. Obes Res 2004, 12(8):1217-1222.
9. Wolfs M.G., Rensen S.S., Bruin-Van Dijk E.J., Verdam F.J., Greve J.W., Sanjabi B., et al. Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study. BMC Med Genomics 2010, 3:34.
10. Samaras K., Botelho N.K., Chisholm D.J., Lord R.V. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity 2010, 18:884-889.
11. Fox C.S., Massaro J.M., Hoffmann U., Pou K.M., Maurovich-Horvat P., Liu C.Y., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
12. Dolinková M., Dostálová I., Lacinová Z., Michalský D., Haluzíková D., Mráz M., et al. The endocrine profile of subcutaneous and visceral adipose tissue of obese patients. Mol Cell Endocrinol 2008, 291:63-70.
13. Fain J.N. Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm 2010, 2010:513948.
14. Gnanadesikan R., Kettenring J.R. Robust estimates, residuals, and outlier detection with multiresponse data. Biometrics 1972, 28:81-124.
15. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
16. Hamdy O., Porramatikul S., Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006, 2:367-373.
17. Hube F., Birgel M., Lee Y.M., Hauner H. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1999, 29:672-678.
18. Moschen A.R., Molnar C., Enrich B., Geiger S., Ebenbichler C.F., Tilg H. Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss. Mol Med 2011, 17:840-845.
19. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 1999, 162:4511-4520.
20. Puren A.J., Razeghi P., Fantuzzi G., Dinarello C.A. Interleukin-18 enhances lipopolysaccharide-induced interferon-gamma production in human whole blood cultures. J Infect Dis 1998, 178:1830-1834.
21. Netea M.G., Joosten L.A., Lewis E., Jensen D.R., Voshol P.J., Kullberg B.J., et al. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat Med 2006, 12:650-656.
22. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
23. Koenen T.B., Stienstra R., van Tits L.J., Joosten L.A., van Velzen J.F., Hijmans A., et al. The inflammasome and caspase-1 activation: a new mechanism underlying increased inflammatory activity in human visceral adipose tissue. Endocrinology 2011, 152:3769-3778.
24. Ridker P.M., Rifai N., Pfeffer M., Sacks F., Lepage S., Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000, 101:2149-2153.
25. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836-843.
26. Rothenbacher D., Müller-Scholze S., Herder C., Koenig W., Kolb H. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler Thromb Vasc Biol 2006, 26:194-199.
27. Di Iorio A., Ferrucci L., Sparvieri E., Cherubini A., Volpato S., Corsi A., et al. Serum IL-1beta levels in health and disease: a population-based study. 'The InCHIANTI study'. Cytokine 2003, 22:198-205.
28. Blankenberg S., Luc G., Ducimetière P., Arveiler D., Ferrières J., Amouyel P., et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003, 108:2453-2459.
29. Wallace A.M., McMahon A.D., Packard C.J., Kelly A., Shepherd J., Gaw A., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001, 104:3052-3056.
30. Reilly M.P., Lehrke M., Wolfe M.L., Rohatgi A., Lazar M.A., Rader D.J. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005, 111:932-939.